These findings first reported the anti-breast cancer effect of MA, pointed out GADD45A as the direct target of miR-374a in breast cancer, and partly offered evidence for S. suberectus as a resource of novel drug candidates in TNBC therapy. The gene discussed is GADD45A; the disease is breast cancer.